Efficacy and Safety of Ombitasvir, Paritaprevir and Ritonavir plus Ribavirin in Hepatitis C Genotype-4 Patients on Hemodialysis
Background: The ongoing standard treatment for patients with chronic hepatitis C virus (HCV) is a mixture of direct-acting antiviral agents (DAAs). Aim of work: the aim of this study is to analyse the efficacy and safety of oral interferon-free regimen of ombitasvir, and paritaprevir with ritonavir,...
Salvato in:
| Autori principali: | , , , |
|---|---|
| Natura: | Libro |
| Pubblicazione: |
Ain Shams University,
2020-09-01T00:00:00Z.
|
| Soggetti: | |
| Accesso online: | Connect to this object online. |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne!!
|
Accesso online
Connect to this object online.3rd Floor Main Library
| Collocazione: |
A1234.567 |
|---|---|
| Copia 1 | Disponibile |